MRI as a Novel In Vivo Approach for Assessing Structural Changes of Chlamydia Pathology in a Mouse Model

Catherine D G Hines1, Shubing Wang2, Xiangjun Meng1

  • 1Department of Translational Imaging Biomarkers, MRL (West Point, PA), Merck & Co., Inc., Kenilworth, New Jersey, United States of America.

Plos One
|July 29, 2016
PubMed

Insights

Chlamydia trachomatis infections are common and recurring, necessitating a vaccine. Magnetic Resonance Imaging (MRI) offers a non-invasive method to assess Chlamydia pathology and evaluate vaccine efficacy in mice.

Area of Science:

  • Medical Imaging
  • Infectious Diseases
  • Vaccinology

Background:

  • Chlamydia trachomatis is a prevalent sexually transmitted infection with increasing rates despite enhanced surveillance.
  • Recurrent Chlamydia infections and associated pathology highlight the need for effective preventative strategies, such as vaccination.
  • Current methods for assessing Chlamydia pathology in vaccine research are often invasive and time-consuming.

Purpose of the Study:

  • To evaluate the utility of longitudinal T2-weighted MRI for non-invasively assessing Chlamydia muridarum infection and related pathology in a mouse model.
  • To investigate the potential of MRI as a clinically translatable method for evaluating Chlamydia vaccine efficacy.
  • To develop and apply a scoring system for quantifying Chlamydia-induced pathology over time using MRI.

Main Methods:

  • Longitudinal T2-weighted MRI was performed on mice challenged with Chlamydia muridarum over 63 days.
  • Mice were either immunized with elementary bodies (EB) or received no immunization.
  • A standardized scoring system was used to quantify pathology, with gross necropsy performed on day 65 for comparison.

Main Results:

  • Unimmunized, challenged mice showed significantly increased pathology by day 21 compared to control and EB-immunized groups.
  • No significant differences in pathology were observed between unchallenged and EB-immunized, challenged mice.
  • MRI scores at day 63 generally correlated with gross necropsy scores at day 65, indicating MRI's potential for pathology assessment.

Conclusions:

  • MRI is a promising non-invasive tool for evaluating Chlamydia muridarum infection and pathology in vivo.
  • This MRI technique can potentially streamline the assessment of Chlamydia vaccine candidates.
  • The study demonstrates MRI's utility in tracking disease progression and evaluating the impact of immunization in Chlamydia infection models.